CDKN2A and familial melanoma: Subsequently, Nishisho et al found mutations in adenomatous polyposis coli (APC) in familial adenomatous polyposis (14), and Hussussian et al identified mutations in cyclin-dependent kinase inhibitor 2A (CDKN2A) in familial melanoma (15).